Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the ...

Scientists turn dental floss into a vaccine tool that protected mice from lethal flu and triggered widespread immune response ...

One dose of the HPV vaccine in girls aged 9–14 triggers strong, lasting immune responses, comparable to a full three-dose ...

In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just ...

A new scientific discovery is offering a promising breakthrough for people struggling with hay fever and asthma triggered by ...

Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in ...

But one thing is becoming clear: antibodies might not be telling the whole story when it comes to COVID-19 immunity. “We shouldn’t just look blindly at antibody tests,” Aleman says.

The fatality rate for H5N1 highly pathogenic avian influenza in humans has historically been high, with more than half of ...

A new research paper was published in Volume 16 of Oncotarget on July 9, 2025, titled “A novel anti-human CD25 mAb with ...